A 50-patient study explores lithotripsy-assisted stenting for calcified left main coronary disease, reporting expansion and ...
SANTA CLARA, Calif., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ...
SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...
FastWave Medical's laser intravascular lithotripsy system successfully fractured calcified coronary artery lesions in 30 ...
SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...
FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, today announced positive interim results ...
Shockwave Medical, Inc. SWAV recently commercially launched the Shockwave M5+ peripheral intravascular lithotripsy (“IVL”) catheter. Commercial availability of the product in Europe and the United ...
Medical professionals at a Noida hospital have successfully treated a 76-year-old patient with severe arterial calcification ...
FastWave Medical pioneers next-generation intravascular lithotripsy (IVL) technology to transform the treatment of calcific artery disease in peripheral and coronary applications. Pulse 2.0 ...
WASHINGTON--(BUSINESS WIRE)--Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced positive six-month data from the PINNACLE I study evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results